Tellus Therapeutics
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
517 Summit Trail Dr, Hillsborough, North...Phone Number
(919) 491-4995Website
www.tellustherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Tellus Therapeutics
Tellus Therapeutics is dedicated to transforming care for premature infants suffering from brain and gut injuries by pioneering the first myelination therapy for neonatal white matter injury. Their mission focuses on addressing critical gaps in NICU care and establishing a regenerative medicine platform that could revolutionize treatment for myelination and inflammation-related diseases. The company aims to alleviate the suffering of vulnerable families and advance neuro-regenerative medicine from early infancy to adulthood. Their pipeline includes innovative neonatal therapeutics, starting with TT-20 for white matter brain injury.Explore more
Tellus Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tellus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Tellus Therapeutics had a recent Job posting/layoffs
Check if Tellus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Tellus Therapeutics
Earning: See what the market has to say on Tellus Therapeutics recently announced quarterly report
Check out if Tellus Therapeutics is spiking on competitors!
Tellus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Tellus Therapeutics launches new products
Funding: Get notified immidiatlly once Tellus Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Tellus Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Tellus Therapeutics
Compare insights from companies similar to Tellus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tellus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tellus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tellus Therapeutics.
Tellus Therapeutics financials insights
Gather financial insights about Tellus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$35M
Tellus Therapeutics Tech Stack
A closer look at the technologies used by Tellus Therapeutics
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Tellus Therapeutics is planning to move its offices in March 2023. The move will impact approximately 7 employees at their existing office located at 517 Summit Trail Dr., Hillsborough, NC.
Funding
Funding
Funding
Tellus Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Tellus Therapeutics
Sign Up For FreeTo access detailed company insights
Tellus Therapeutics is dedicated to transforming care for premature infants suffering from brain and gut injuries by pioneering the first myelination therapy for neonatal white matter injury. Their mission focuses on addressing critical gaps in NICU care and establishing a regenerative medicine platform that could revolutionize treatment for myelin... Read More
